期刊文献+

中国患者奥沙利铂过敏反应文献分析 被引量:5

Literature analysis of Oxaliplatin Allergic Reactions in Chinese patients
下载PDF
导出
摘要 目的搜集中国患者奥沙利铂(oxaliplatin,OXA)过敏反应的病例报道文献,总结其特点及规律,以提高OXA临床应用安全性。方法检索万方数据和中国知网等中文文献数据库中OXA过敏反应相关病例报道文献,从患者性别、年龄、化疗周期、过敏反应发生时间、给药剂量、临床表现、严重程度和转归等方面进行统计和分析,检索时间为1999年1月1日至2019年5月31日。结果共纳入OXA过敏反应102例报告,患者平均年龄53岁,男女比例为1.04:1。OXA过敏反应可发生在用药的任何周期,过敏反应发生时间主要集中在30 min内,可累及消化、心血管、呼吸等多个系统。文献报道的OXA过敏反应中Ⅲ级较多,所有病例在停药或治疗后均好转。结论过敏反应是OXA常见药品不良反应,可导致化疗中断,严重过敏反应甚至对患者生命安全造成威胁。临床医护人员应关注OXA的过敏反应,加强监测和防治工作,提高患者用药安全性。 Objective To collect case reports on oxaliplatin(OXA)-induced allergic reactions in Chinese patients,summarize their characteristics and regularities,and improve the safety of OXA in clinical application.Methods Chinese literature databases including Wanfang and CNKI etc from January 1999 fo May 2019.were searched for case reports of OXA-induced allergic reactions.Data on gender,age,chemotherapy cycles,the time allergic reactions occurred,dosage,clinical manifestations,severity and outcomes of the patients was statistically analyzed.Results A total of 102 OXA allergic reactions were reported.The average age of patients was 53 years old and the male-female ratio was 1.04:1.OXA-induced allergic reactions can occur in any cycle of medication,mostly within 30min,which can involve multiple systems such as digestive,cardiovascular and respiratory systems.Most of these allergic reactions are grade III,and all of these cases have improved after drug withdrawal or treatment.Conclusion Allergic reactions are common with OXA,which can lead to the interruption of chemotherapy.Severe allergy even poses a threat to patients'safety.The clinical medical staff should be alert to the allergic reactions of OXA,strengthen monitoring and prevention,and improve the safety of medication for patients.
作者 李敏 钟巧妮 赵丽 兰露露 刘东 张程亮 LI Min;ZHONG Qiaoni;ZHAO Li;LAN Lulu;LIU Dong;ZHANG Chengliang(Department of Pharmacy,Tongji Hospital Affiliated to Tongji Medical College,Huazhong University of Science and Technology,Wuhan Hubei 430030,China;Department of Pharmacy,Zhongnan Hospital of Wuhan University,Wuhan Hubei 430071,China;Hubei Center for ADR/ADE Monitoring,Wuhan Hubei 430071,China)
出处 《中国药物警戒》 2020年第11期798-802,共5页 Chinese Journal of Pharmacovigilance
基金 湖北省药品(医疗器械)不良反应监测中心课题(20160422) 华中科技大学同济医学院研究型临床医师资助计划(5001540076)。
关键词 奥沙利铂 药品不良反应 过敏反应 用药安全 oxaliplatin ADR allergic reactions drug safety
  • 相关文献

参考文献2

二级参考文献19

共引文献21

同被引文献36

引证文献5

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部